madman
Super Moderator
Prostate cancer screening is an essential aspect of men’s health, and current advancements in testing are making early detection more precise than ever before.
While the PSA (Prostate-Specific Antigen) test has long been the standard, it has limitations and may lead to unnecessary biopsies. The new EpiSwitch PSE test helps differentiate between high and low prostate cancer risks. With an impressive 94% accuracy rate, the EpiSwitch PSE test empowers patients and physicians to make informed decisions.
In this episode, Dr. Garrett Pohlman explores the latest innovations in prostate cancer screening, focusing on the EpiSwitch PSE blood test.
Stay tuned to discover the benefits of the new EpiSwitch PSE test and learn how precision medicine is reshaping prostate cancer management for men
----------
Show Highlights:
* What are the limitations of the PSA test?
* How the EpiSwitch PSE test can predict the risk of prostate cancer with 94% accuracy
* How prostate cancer biomarkers help to identify the likelihood of prostate cancer
* How the EpiSwitch PSE test can provide a more accurate assessment of prostate cancer risk
* How the EpiSwitch PSE test can help men avoid unnecessary biopsies
* The clinical applications of the EpiSwitch PSE test and how it can be used alongside a standard PSA test to improve accuracy
* How the EpiSwitch PSE test requires just two milliliters of blood
* How even patients who have undergone recent BPH procedures or are on 5-alpha reductase inhibitors can use the EpiSwitch PSE test
* Why the EpiSwitch PSE test is more accurate than PSA testing
* Why men need to be aware of their PSA numbers and consider additional testing if they have an elevated PSA
While the PSA (Prostate-Specific Antigen) test has long been the standard, it has limitations and may lead to unnecessary biopsies. The new EpiSwitch PSE test helps differentiate between high and low prostate cancer risks. With an impressive 94% accuracy rate, the EpiSwitch PSE test empowers patients and physicians to make informed decisions.
In this episode, Dr. Garrett Pohlman explores the latest innovations in prostate cancer screening, focusing on the EpiSwitch PSE blood test.
Stay tuned to discover the benefits of the new EpiSwitch PSE test and learn how precision medicine is reshaping prostate cancer management for men
----------
Show Highlights:
* What are the limitations of the PSA test?
* How the EpiSwitch PSE test can predict the risk of prostate cancer with 94% accuracy
* How prostate cancer biomarkers help to identify the likelihood of prostate cancer
* How the EpiSwitch PSE test can provide a more accurate assessment of prostate cancer risk
* How the EpiSwitch PSE test can help men avoid unnecessary biopsies
* The clinical applications of the EpiSwitch PSE test and how it can be used alongside a standard PSA test to improve accuracy
* How the EpiSwitch PSE test requires just two milliliters of blood
* How even patients who have undergone recent BPH procedures or are on 5-alpha reductase inhibitors can use the EpiSwitch PSE test
* Why the EpiSwitch PSE test is more accurate than PSA testing
* Why men need to be aware of their PSA numbers and consider additional testing if they have an elevated PSA
